中国药业2016，Vol.25Issue(1)：72-74,3.
我院2011年至2013年免疫增强药物利用分析
Utilization of Immune-Enhancing Drugs in the Hospital from 2011 to 2013
陈尚瑜 1杨建锋 1费燕1
作者信息
- 1. 中国人民解放军第一七五医院·厦门大学附属东南医院药学科，福建 漳州 363000
- 折叠
摘要
Abstract
Objective To analyze the utilization of immune-enhancing drugs in the hospital and provide evidence for the rational use of these drugs. Methods The amount of sorting method and DDDs method were used to statistically analyze the clinical use of immune-enhancing drugs in our hospital from 2011 to 2013. Results The amount of sales and DDDs of immune-enhancing drugs in the hos-pital had increased year by year. For the latest 3 years, the sales amount of RNA Ⅱwas always in the first place, ubenimex came in last, the sales amount of spleen aminopeptidaset increased mostly, while mannatides were running down; Thymopentin ranked first in DDDs, and intravenous human immunoglobulin came in last; all drugs had changes with DDC, among which thymopentin had declined year by year, while thymosin α1 had increased year by year, small changes were found in the other drugs, and with overall stability;thy-mopentin had the highest B/A value, and RNA Ⅱhad the lowest B/A value, mannatide and thymosin α1 had a B/A value closer to 1. 00. Conclusion The utilization of immune-enhancing drug in the hospital is reasonable, but the amount is increasing every year, accompanied by irrational drug use, which needs a better management.关键词
免疫增强药物/用药分析/用药频度/销售金额Key words
immune-enhancing drugs/drug analysis/DDDs/the sales amount分类
管理科学引用本文复制引用
陈尚瑜,杨建锋,费燕..我院2011年至2013年免疫增强药物利用分析[J].中国药业,2016,25(1):72-74,3.
